Zotefoams plc (LON:ZTF - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 295.08 ($3.99) and traded as low as GBX 272.32 ($3.68). Zotefoams shares last traded at GBX 275 ($3.72), with a volume of 91,371 shares.
Zotefoams Stock Up 5.4%
The company has a market capitalization of £149.10 million, a price-to-earnings ratio of 15.01, a price-to-earnings-growth ratio of 0.66 and a beta of 1.40. The firm's 50-day simple moving average is GBX 262.41 and its 200-day simple moving average is GBX 293.51. The company has a debt-to-equity ratio of 42.07, a quick ratio of 0.67 and a current ratio of 1.30.
Zotefoams (LON:ZTF - Get Free Report) last issued its earnings results on Tuesday, March 18th. The company reported GBX 25.95 ($0.35) EPS for the quarter. Zotefoams had a return on equity of 8.42% and a net margin of 7.45%.
Zotefoams Increases Dividend
The business also recently disclosed a dividend, which will be paid on Monday, June 2nd. Shareholders of record on Thursday, May 1st will be paid a dividend of GBX 5.10 ($0.07) per share. This is a positive change from Zotefoams's previous dividend of $2.38. This represents a yield of 1.92%. The ex-dividend date is Thursday, May 1st. Zotefoams's dividend payout ratio is currently 33.89%.
About Zotefoams
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Further Reading
Before you consider Zotefoams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zotefoams wasn't on the list.
While Zotefoams currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
